The National Procurement Policy Statement this month applies to all contracting authorities who are subject to the procurement rules. Whilst broadly welcomed it raises a number of practical challenges for local authorities and the wider public sector.
The Treasury has issued new guidance which relates to 'Special Severance Payments' (SSPs) made by public sector employers to their employees. The guidance sets out the criteria that should be considered and steps to take to obtain Treasury approval.
The Employment Appeal Tribunal (EAT) has held that in the Mercer v Alternative Future Group Ltd the scope of trade union activities under s146 of TULRCA is to be interpreted as encompassing participation in industrial action.
A new Bill aims to introduce important changes to the director disqualification regime in England and Wales and will extend investigative powers to include former directors of dissolved companies. What changes could be on the horizon?
The UK has all the ingredients to be at the forefront of life sciences, with the links between world-leading academia, industry and care system. Never has this been more apparent than the starring role the UK took in the fight against COVID-19.
The Divorce, Dissolution and Separation Act 2020 will come into force on 6 April 2022. Whilst the date is later than originally indicated, it is now fixed as a matter of Parliamentary record and we can look forward with certainty.
Transparency about beneficial ownership is recognised as a key way of combatting money laundering and terrorist activity. The EU has introduced a number of Money Laundering Directives, with this in mind.
Many leases require the landlord to keep parts of the property in repair, and tenants to contribute to the cost of those repairs through a service charge. Difficulties can arise when considering who should pay to repair inherent defects in the property.
Babies in the UK have started to receive Zolgensma, from Novartis Gene Therapies, on the NHS following a confidential deal. The drug, valued at £1.8m per treatment, is one of the most expensive medicines on the market.